Abstract
Our recently confirmed knowledge has indicated that the lymphatics are more important than previously thought in maintaining cellular well-being and tissue homeostasis – given that there is no longer any significant reuptake of what leaks out of the vascular system back into it and that the lymphatics are solely responsible for it. Lymphokines, cytokines, inflammatory mediators, and adipogenic factors are all dependent on the lymphatics for their tissue clearance.
The breadth of treatment options continues to widen, with not all being well evidenced. There remain differences of opinion regarding the benefit of even traditional treatment forms such as manual lymphatic drainage and compression, so it is no great wonder when patients and practitioners shift toward alternate treatment modalities.
The roles and effectiveness of pressure have been reviewed with some indications emerging that often good outcomes are not gained due to an inappropriate pressure or a poor pressure gradient or perhaps a lack of thought as to what part of the lymphatic or venous systems need compression. There is also a trend to wider use of negative pressures over the superficial lymphatics, these being created by various forms of lymph taping and by a range of units which deliver a negative suction on the skin.
With so many conservative therapies around, it is hard for even an informed patient or clinician to make the right decision for the patient in front of them. The solution of course is to carefully review the range of best practice documents and perhaps consider using only one new or contemporary or traditional treatment at a time and giving it time to work before deciding if that is optimal or beneficial for the patient.
We have a plethora of treatments and strategies for dealing with lymphedema. Some show scant evidence of their effectiveness and often little rationale for their use. We must advance our knowledge in the breadth of treatments with an open mind, but must provide evidence for their efficacy so that patients and practitioners know what to expect.
For many new treatments, the trials are often small, but some are well designed and are objective with rigorous evaluation, so we can have confidence in the outcomes. Many contemporary treatments start as a good case study and move to a small clinical trial, but for many of these, their construct and conduct can leave many unanswered questions and skepticism leading to the loss of an opportunity to broaden our treatment base.
Highlighted References
Farinola N, Piller N. Pharmaco-genomics—its role in re-establishing coumarin as treatment for lymphoedema. Lymphat Res Biol. 2005;3(2):81. PubMed CrossRef.
Omar MT, Shaheen AA, Zafar H. A systematic review of the effect of low level laser therapy in the management of breast cancer related lymphoedemalymphedema. Support Care Cancer. 2012;20(11):2977–84.
Moseley AL, Carati C, Piller NB. A systematic review of common conservative therapies for arm lymphoedema secondary to breast cancer treatment. Ann Oncol. 2003. doi:10.1093/annonc/md182.
Deng J, Fu MR, Armer JM, Cormier JN, Radina E, Thiadens SR, Dietrich MS, Weiss J, Tuppo CM, Ridner SH. Self reported information sources and perceived knowledge in individuals with lymphoedema. Lymphology. 2013;46(4):173–83.
Lundquist H, Enblom A, Dunberger G, Nyberg T, Bergmark K. Water exercise compared to land exercise or standard care in female cancer survivors with secondary lymphoedema. Lymphology. 2015;48(2):64–79.
References
Mulrow C, Oxman A. How to conduct a Cochrane systematic review. 3rd ed. London: BMJ Publishing Group; 1996.
Moseley A, Piller NB, Douglass J, Esplin M. Comparison of the effectiveness of MLD and LPG. J Lymphoedema. 2007a;2(2):3036.
Pecking AP, Fevrier B, Wargon C, Pillion G. Efficacy of Daflon 500 mg in the treatment of lymphedema (secondary to conventional therapy of breast cancer). Angiology. 1997;48(1):93–8. PubMed CrossRef.
Cluzan RV, Alliot F, Ghabboun S, Pascot M. Treatment of secondary lymphedema of the upper limb with cyclo 3 fort. Lymphology. 1996;29:29–35. PubMed.
Casley-Smith JR, Morgan RG, Piller NB. Treatment of lymphedema of the arms and legs with 5,6-BENZO-[á]-PYRONE. N Engl J Med. 1993;329(16):1158–63. PubMed CrossRef.
Loprinzi CL, Kugler JW, Sloan JA, et al. Lack of effect of Coumarin in women with lymphedema after treatment for breast cancer. N Engl J Med. 1999;340(5):346–50. PubMed CrossRef.
Piller N, Thelander A. Treatment of chronic lymphoedema with low level laser therapy: a 2.5 year follow-up. Lymphology. 1998;31(2):74. PubMed.
Carney SA, Lauwrence JC, Ricketts CR. The effect of light from a ruby laser on mesothelium of skin in tissue culture. Biochem Biophys Acta. 1967;148(2):525–30. PubMed.
Carati CJ, Anderson SN, Gannon BJ, Piller NB. Treatment of postmastectomy lymphedema with low-level laser therapy. Cancer. 2003;98(6):1114–22. PubMed CrossRef.
Maiya A, Olivia E, Dibya A. Effect of low energy laser therapy in the management of post mastectomy lymphoedema. Singapore J Physiother. 2008;11(1):2–5.
Tilley S. Use of laser therapy in the management of lymphoedema. J Lymphoedema. 2009;4(1):39–72.
Williams A. Manual lymphatic drainage: exploring the history and evidence base. Br J Community Nurs. 2010;15:S18–24. PubMed.
Piller NB, Rice J, Heddle R, Miller A. Partner training as an effective means of managing chronic arm lymphoedema subsequent to breast cancer surgery. Proceedings of the XV Lymphology Congress Lymphology. 2000;33(suppl):261.
Moseley A, Piller NB, Heidenreich B, Douglass J. Pilot study of hand-held massage unit. J Lymphoedema. 2009;4(1):23–7.
Moseley A et al. A new patient focused, home based therapy for people with chronic lymphoedema. Lymphology. 2004;37(1):53. PubMed.
Moseley A, Piller NB. The effect of gentle arm exercise and deep breathing on secondary arm lymphoedema. Lymphology. 2005;38(4):229.
Moseley A, Piller NB. Exercise for limb lymphoedema: evidence that it is beneficial. J Lymphoedema. 2008;3(1):51–6.
Johansson K, Tibe K, Kanne L, Skantz H. Controlled physical training for arm lymphoedema patients. Lymphology. 2004;37(suppl):37–9.
Box R, Marnes T, Robertson V. Aquatic physiotherapy and breast cancer related lymphoedema. 5th Australasian Lymphology Association Congress Proceedings. 2004. 37–42.
Tidar D, Katz-Leurer M. Aqua lymphatic therapy in patients who suffer from breast cancer related lymphoedema: a randomized controlled study. Support Care Cancer. 2010;18(3):383–92. CrossRef.
Casley-Smith JR, Casley-Smith JR. Modern treatment for lymph edema. 5th ed: Lymphoedema Association of Australia, Malvern, South Australia, 1997.
Bracha J, Jacob T. Using exercise classes to reduce lymphoedema. J Lymphoedema. 2010;5(1):46–55.
Johanssen K, Piller NB. Exercises with heavy weights for patients with breast cancer related lymphoedema 2005: XXth International Congress Lymphology, Salvador, Brazil, Proceedings. 2005.
Johansson K. Weight bearing exercise and its impact on arm lymphoedema. J Lymphoedema. 2007;2(2):115–22.
Todd J, Scally A, Dodwell D, Horgan K, Topping A. A randomized controlled trial of two programs of shoulder exercise following axillary node dissection for invasive breast cancer. Physiotherapy. 2008;94:265–73.
Piller NB, Douglass J, Heidenreich B, Moseley A. Placebo controlled trial of mild electrical stimulation. J Lymphoedema. 2010;5(1):15–25.
Moseley A, Esplin M, Piller NB, Douglass J. Endermologie (with and without compression bandaging) a new treatment option for secondary arm lymphoedema. Lymphology. 2007b;40:128–37.
Rock-Stockheimer K. Kinesiotaping for Lymph Edema and Chronic Swelling. USA: Kinesio; 2006.
Kinesio UK Kinesio Taping for Lymph edema. Available online at: www.kinseiotaping.co.uk. Accessed 13 May 2009.
Finnerty S, Thomason S, Woods M. Audit of the use of kinesiology tape for breast oedema. J Lymphoedema. 2010;5(1):38–44.
Bosman J, Piller NB. A randomized clinical trial of lymph taping in seroma formation after breast cancer surgery. J Lymphoedema. 2010;5(2):12–23.
Foeldi M, Foeldi E, (eds). Lymphatic diseases (Chylous Refluxpp 244) In: Textbook of Lymphology. 2012, Urban and Fisher.
Haour F. Mechanisms of placebo effect and of conditioning: neurobiological data in human and animals. Med Sci. 2005;21(3):315–9.
Hrobjartsson A, Gotzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med. 2001a;344(21):1594–602.
Campisi CC, Ryan M, Campisi CS, Di Summa P, Boccado F, Campisi C. Internmittent negative pressure therapy in the combined treatment of peripheral lymphoedema. Lymphology. 2015;48(4):197–204.
Benson H, Friedman R. Harnessing the power of the placebo effect and renaming it “remembered wellness”. Annu Rev Med. 1996;47:193–9.
Papakostas YG, Daras MD. Placebos, placebo effect, and the response to the healing situation: the evolution of a concept. Epilepsia. 2001;42(12):1614–25.
Dawson R, Piller N. Diet and BCRL: Facts and Falacies on the Web. J Lymphoedema. 2011;6(1):36–43.
Johansson K, Karlsson K, Nikolaidis P. Evidence – based or traditional treatment of cancer related lymphoedema. Lymphology. 2015;48(1):24–37.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Piller, N. (2018). Other Contemporary Treatment Modalities. In: Lee, BB., Rockson, S., Bergan, J. (eds) Lymphedema. Springer, Cham. https://doi.org/10.1007/978-3-319-52423-8_35
Download citation
DOI: https://doi.org/10.1007/978-3-319-52423-8_35
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52421-4
Online ISBN: 978-3-319-52423-8
eBook Packages: MedicineMedicine (R0)